Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 23/03/31

Trade details

Type
Insider sale
Amount
$874,100.62
Shares · price
4,027 sh · $217.06 a share
Held after
4,103 sh
Trade date
23/03/29
Filed
23/03/31
Days to filing
2 days

Sold 49.5% of holdings

Share of holding sold
49.5%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/27~23/04/28

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $220.2K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $218.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $153.5K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $131.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $114.8K

    Filed 10/01

Martine A. Rothblatt, Chairman — sold $874.1K of United Therapeutics UTHR · 49.5% of holdings | Whalegun